Bruce A. Hironaka
Profile
Bruce A.
Hironaka was the founder of IgGenix, Inc. (founded in 2019) where he held the title of Chief Executive Officer & Director.
Mr. Hironaka is also the founder of Agenovir Corp.
He previously worked as President & Chief Executive Officer at Thios Pharmaceuticals, Inc. Mr. Hironaka received his undergraduate degree from the University of California, Berkeley and his graduate degree in MBA from Stanford University.
Former positions of Bruce A. Hironaka
| Companies | Position | End |
|---|---|---|
Agenovir Corp.
 Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Founder | 2016-12-07 |
IgGenix, Inc.
 IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Founder | - |
Thios Pharmaceuticals, Inc.
 Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | President | - |
Training of Bruce A. Hironaka
| Stanford University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Thios Pharmaceuticals, Inc.
Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | Health Technology |
Agenovir Corp.
Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Health Technology |
IgGenix, Inc.
IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Bruce A. Hironaka
